News tagged with immunosuppressant drugs
Discovery may lead to development of safer immunosuppressants
Mar 12, 2009 |
5 / 5 (1) |
0
Immunosuppressive treatment is necessary to prevent rejection of an organ after transplant and has great potential for treating chronic inflammatory diseases. However, currently available immunosuppressant drugs can pose ...
Search results for immunosuppressant drugs
More stringent evaluation on the use of generic medications in thoracic transplantation
Jun 02, 2009 |
not rated yet |
0
A closer look at regulatory and clinical concerns with generic immunosuppression medications in thoracic transplantation is required, according to an educational advisory by the International Society for Heart and Lung Transplantation ...
'Multi-target' immune therapy improves outcomes of severe lupus nephritis
Jul 02, 2008 |
not rated yet |
0
A new treatment using a combination of drugs targeting different parts of the immune system improves the recovery rate for patients with severe lupus involving the kidneys, according to a report in the October Journal of ...
Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patients
Oct 29, 2009 |
not rated yet |
0
A recent study by Swedish researchers found that rheumatoid arthritis (RA) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (TNF) therapy. The research team, ...
Switching immunosuppressants reduces cancer risk in kidney
Nov 02, 2009 |
not rated yet |
0
Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and ...
FDA issues Myfortic tablets safety alert
Medicine & Health / Medications
Nov 28, 2007 |
not rated yet |
0
The U.S. Food and Drug Administration issued a safety alert for pregnant patients using the kidney transplant drug Myfortic delayed-release tablets.
Promising new drug targets identified for Huntington's disease
Mar 23, 2008 |
4.5 / 5 (8) |
0
Research funded by the Wellcome Trust has provided a number of promising new drug targets for Huntington's disease, a neurodegenerative disease. Scientists at the University of Cambridge have identified a number of candidate ...
Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
May 19, 2008 |
not rated yet |
0
New research published in the Journal of the American College of Surgeons shows long-term survival and liver rejection rates are equivalent for African-American liver transplant patients as compared with patients of other ...
Risk of leukemia with multiple sclerosis drug higher than thought
Apr 30, 2009 |
not rated yet |
1
The risk of developing leukemia as a side effect of a drug for multiple sclerosis (MS) is higher than previously reported, according to a study to be presented as part of the Late-breaking Science Program at the American ...
Cancer drug shows promise against graft vs. host disease
Jul 10, 2008 |
not rated yet |
0
A new University of Michigan study in mice suggests that a drug recently approved to fight cancer tumors is also able to reduce the effects of graft-versus-host disease, a common and sometimes fatal complication ...
Researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin
Nov 03, 2009 |
4.5 / 5 (2) |
0
Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have for the first time successfully reconstituted in the laboratory the enzyme responsible for producing the blockbuster cholesterol-lowering ...
List of search results for immunosuppressant drugs
